Orbimed Advisors - HERON THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$826,781
-11.2%
802,7000.0%0.02%
+5.9%
Q2 2023$931,132
-23.2%
802,7000.0%0.02%
-29.2%
Q1 2023$1,212,077
-74.4%
802,700
-28.5%
0.02%
-72.7%
Q3 2022$4,739,000
-81.2%
1,123,000
-5.8%
0.09%
-60.2%
Q4 2020$25,225,000
+42.8%
1,191,8460.0%0.22%
-0.5%
Q3 2020$17,663,000
+81.8%
1,191,846
+80.5%
0.22%
+62.0%
Q2 2020$9,715,000
+54.0%
660,420
+22.9%
0.14%
+29.2%
Q1 2020$6,309,000
-75.9%
537,420
-49.7%
0.11%
-73.8%
Q1 2019$26,126,000
-28.1%
1,069,000
-23.7%
0.40%
-39.9%
Q4 2018$36,324,000
-24.2%
1,400,300
-7.5%
0.67%
+16.5%
Q3 2018$47,934,000
-6.2%
1,514,500
+15.2%
0.58%
-5.3%
Q2 2018$51,092,000
+62.4%
1,315,100
+15.4%
0.61%
+56.2%
Q1 2018$31,458,000
+167.4%
1,139,800
+75.4%
0.39%
+161.7%
Q4 2017$11,765,000
+12.1%
650,0000.0%0.15%
+49.0%
Q3 2017$10,498,000
+16.6%
650,0000.0%0.10%
+6.4%
Q2 2017$9,003,000
-7.7%
650,0000.0%0.09%
-15.3%
Q1 2017$9,750,000650,0000.11%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders